1/16/24 16:36 | 1/16/24 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | P | 29 | 14.50 | 0 | 2 | 3 | 81 | D | | | | | | | | | | | | | | |
12/29/23 16:15 | 12/28/23 | AVDL | Health | Drug | Pharmaceutical Preparations | McCamish Mark Anthony | L2 | D | | S | -1,090 | 14.53 | 0 | -75 | -53 | 67 | I | | | | | | | | | | | | | | |
8/15/23 16:13 | 8/11/23 | AVDL | Health | Drug | Pharmaceutical Preparations | McCamish Mark Anthony | L2 | D | | S | -433 | 14.93 | 0 | -29 | -17 | 142 | I | | | | | | | | | | | | | | |
8/14/23 17:56 | 8/14/23 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | P | 29 | 14.45 | 0 | 2 | 3 | 79 | D | | | | | | | | | | | | | | |
8/11/23 16:00 | 8/10/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | | P | 188 | 13.40 | 0 | 14 | 13 | 125 | I | | | | | | | | | | | | | | |
8/10/23 18:45 | 8/10/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Gregory J | L2 | DO | CEO | P | 132 | 13.20 | 0 | 10 | 7 | 159 | D | | | | | | | | | | | | | | |
5/19/23 16:16 | 5/18/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P | 181 | 13.93 | 0 | 13 | 8 | 168 | D | | | | | | | | | | | | | | |
5/10/23 16:12 | 5/9/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Palczuk Linda | L2 | D | | P | 37 | 14.76 | 0 | 3 | 5 | 52 | D | | | | | | | | | | | | | | |
12/28/22 16:02 | 12/23/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Palczuk Linda | L2 | D | | P | 14 | 7.20 | 0 | 2 | 4 | 50 | D | | | | | | | | | | | | | | |
11/30/22 16:01 | 11/29/22 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | P | 39 | 7.80 | 0 | 5 | 7 | 77 | D | | | | | | | | | | | | | | |
11/23/22 16:01 | 11/22/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P | 156 | 7.80 | 0 | 20 | 15 | 155 | D | | | | | | | | | | | | | | |
6/3/22 18:05 | 5/31/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | | P.a | 96 | 2.14 | 0 | 45 | New | 45 | I | | | | | | | | | | | | | | |
6/2/22 16:02 | 6/1/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | | P | 96 | 2.14 | 0 | 45 | 68 | 111 | I | | | | | | | | | | | | | | |
6/1/22 18:59 | 5/31/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P.m | 78 | 2.23 | 0 | 35 | 35 | 135 | D | | | | | | | | | | | | | | |
5/31/22 07:17 | 5/27/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Palczuk Linda | L2 | D | | P | 16 | 1.60 | 0 | 10 | 26 | 48 | D | | | | | | | | | | | | | | |
5/31/22 07:15 | 5/27/22 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | P | 107 | 2.14 | 0 | 50 | 233 | 72 | D | | | | | | | | | | | | | | |
5/31/22 07:14 | 5/27/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P | 37 | 2.45 | 0 | 15 | 18 | 100 | D | | | | | | | | | | | | | | |
5/31/22 07:13 | 5/27/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Gregory J | L2 | DO | CEO | P | 103 | 2.05 | 0 | 50 | 50 | 149 | D | | | | | | | | | | | | | | |
5/31/22 07:12 | 5/27/22 | AVDL | Health | Drug | Pharmaceutical Preparations | Thornton Peter J. | L2 | D | | P | 85 | 1.69 | 0 | 50 | 151 | 83 | D | | | | | | | | | | | | | | |
9/21/20 16:01 | 9/18/20 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | P | 24 | 6.00 | 0 | 4 | 23 | 22 | D | | | | | | | | | | | | | | |
9/18/20 16:20 | 9/16/20 | AVDL | Health | Drug | Pharmaceutical Preparations | McCamish Mark Anthony | L2 | D | | P.m | 985 | 5.76 | 0 | 171 | New | 171 | I | | | | | | | | | | | | | | |
9/18/20 16:19 | 9/17/20 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P | 98 | 5.79 | 0 | 17 | 25 | 85 | D | | | | | | | | | | | | | | |
9/1/20 16:12 | 8/28/20 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | P | 51 | 6.77 | 0 | 8 | 75 | 18 | D | | | | | | | | | | | | | | |
9/1/20 16:11 | 8/28/20 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | | P | 33 | 6.78 | 0 | 5 | 8 | 66 | D | | | | | | | | | | | | | | |
8/17/20 18:59 | 8/13/20 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | P | 78 | 7.78 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
8/17/20 18:58 | 8/14/20 | AVDL | Health | Drug | Pharmaceutical Preparations | Palczuk Linda | L2 | D | | P | 20 | 7.94 | 0 | 3 | 7 | 38 | D | | | | | | | | | | | | | | |
8/17/20 18:57 | 8/13/20 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P | 39 | 7.79 | 0 | 5 | 8 | 68 | D | | | | | | | | | | | | | | |
8/14/20 18:11 | 8/12/20 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | | P.m | 100 | 7.73 | 0 | 13 | 27 | 61 | D | | | | | | | | | | | | | | |
8/13/20 19:40 | 8/12/20 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P | 116 | 7.76 | 0 | 15 | 31 | 63 | D | | | | | | | | | | | | | | |
8/13/20 19:39 | 8/12/20 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Gregory J | L2 | DO | CEO | P | 101 | 7.78 | 0 | 13 | 15 | 99 | D | | | | | | | | | | | | | | |
12/16/19 16:21 | 12/12/19 | AVDL | Health | Drug | Pharmaceutical Preparations | Hatten Sandra L | L2 | O | See Rema | S | -22 | 7.23 | 0 | -3 | -5 | 59 | D | | | | | | | | | | | | | | |
12/5/19 16:30 | 12/4/19 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P | 60 | 5.97 | 0 | 10 | 26 | 48 | D | | | | | | | | | | | | | | |
12/5/19 16:29 | 12/3/19 | AVDL | Health | Drug | Pharmaceutical Preparations | Palczuk Linda | L2 | D | | P | 44 | 5.91 | 0 | 8 | 27 | 35 | D | | | | | | | | | | | | | | |
11/19/19 17:03 | 11/15/19 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | | P.dm | 100 | 4.99 | 0 | 20 | 72 | 48 | D | | | | | | | | | | | | | | |
11/19/19 17:00 | 11/15/19 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Greg J | L2 | O | CEO | P.d | 97 | 5.13 | 0 | 19 | 28 | 86 | D | | | | | | | | | | | | | | |
11/19/19 16:46 | 11/15/19 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | | P.d | 50 | 4.98 | 0 | 10 | 36 | 38 | D | | | | | | | | | | | | | | |
12/18/18 16:06 | 12/14/18 | FLML | Health | Drug | Pharmaceutical Preparations | Kanan Michael F | L2 | O | See Rema | S.d | -21 | 2.49 | 0 | -8 | -22 | 30 | D | | | | | | | | | | | | | | |
12/18/18 16:04 | 12/14/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Gusky David P | L2 | O | Controll | S.d | -2 | 2.68 | 0 | -1 | -13 | 4 | D | | | | | | | | | | | | | | |
12/18/18 16:01 | 12/14/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Hatten Sandra L | L2 | O | See Rema | S.d | -8 | 2.58 | 0 | -3 | -7 | 44 | D | | | | | | | | | | | | | | |
8/14/18 20:01 | 8/10/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | L2 | DO | CEO | S.d | -80 | 4.91 | 0 | -16 | -6 | 249 | D | | | | | | | | | | | | | | |
8/14/18 20:00 | 8/10/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Hatten Sandra L | L2 | O | See Rema | S.d | -31 | 4.91 | 0 | -6 | -12 | 47 | D | | | | | | | | | | | | | | |
6/29/18 17:24 | 6/26/18 | FLML | Health | Drug | Pharmaceutical Preparations | Kanan Michael F | L2 | O | See Rema | P.d | 11 | 5.70 | 0 | 2 | 5 | 38 | D | | | | | | | | | | | | | | |
6/27/18 19:02 | 6/26/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | L2 | DO | CEO | P.d | 15 | 6.04 | 0 | 3 | 1 | 265 | D | | | | | | | | | | | | | | |
6/27/18 19:00 | 6/26/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Greg J | L2 | O | See Rema | P.d | 96 | 6.00 | 0 | 16 | 48 | 49 | D | | | | | | | | | | | | | | |
6/27/18 18:58 | 6/26/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Thompson Phillandas T. | L2 | O | See Rema | P.d | 58 | 5.77 | 0 | 10 | 12 | 91 | D | | | | | | | | | | | | | | |
6/25/18 17:59 | 6/25/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | *Possibl | S | -683 | 5.99 | 0 | -114 | -3 | 3,675 | I | | | | | | | | | | | | | | |
5/29/18 17:15 | 5/24/18 | AVDL | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | L2 | DO | CEO | P.d | 19 | 6.44 | 0 | 3 | 1 | 263 | D | | | | | | | | | | | | | | |
12/19/17 19:47 | 12/15/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | L2 | D | | P.ad | 1,214 | 8.67 | 0 | 140 | 39 | 503 | M | | | | | | | | | | | | | | |
12/11/17 16:10 | 12/7/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | L2 | DO | CEO | P.d | 44 | 8.86 | 0 | 5 | 2 | 235 | D | | | | | | | | | | | | | | |
11/29/17 16:35 | 11/27/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | L2 | D | | S.d | -2,378 | 9.35 | 0 | -254 | -41 | 363 | D | | | | | | | | | | | | | | |
9/25/17 16:58 | 9/21/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Thornton Peter J. | L2 | D | | P.d | 50 | 9.74 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
9/15/17 16:15 | 9/12/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Hatten Sandra L | L2 | O | See Rema | P.dm | 56 | 9.25 | 0 | 6 | 17 | 41 | M | | | | | | | | | | | | | | |
9/14/17 17:09 | 9/13/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Thompson Phillandas T. | L2 | O | See Rema | P.d | 47 | 9.36 | 0 | 5 | 9 | 63 | D | | | | | | | | | | | | | | |
9/14/17 17:06 | 9/12/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | L2 | D | | P.d | 190 | 9.52 | 0 | 20 | 3 | 634 | I | | | | | | | | | | | | | | |
9/14/17 17:03 | 9/12/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Greg J | L2 | O | See Rema | P.d | 99 | 9.32 | 0 | 11 | New | 11 | D | | | | | | | | | | | | | | |
9/14/17 16:58 | 9/12/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | L2 | DO | CEO | P.d | 39 | 9.80 | 0 | 4 | 2 | 230 | D | | | | | | | | | | | | | | |
6/26/17 16:45 | 6/22/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Broadfin Healthcare Master Fund Ltd | E9 | T | | S.m | -2,787 | 10.68 | 0 | -261 | -6 | 4,133 | D | | | | | | | | | | | | | | |
6/19/17 16:07 | 6/15/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Cerutti Guillaume | L2 | D | | S.d | -278 | 10.46 | 0 | -27 | -53 | 23 | D | | | | | | | | | | | | | | |
5/22/17 18:20 | 5/19/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | L2 | DO | CEO | P.d | 25 | 10.00 | 0 | 3 | 1 | 226 | D | | | | | | | | | | | | | | |
5/22/17 18:17 | 5/18/17 | AVDL | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | L2 | D | | P.dm | 305 | 9.85 | 0 | 31 | 5 | 614 | I | | | | | | | | | | | | | | |
11/30/16 16:18 | 11/28/16 | FLML | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | I0 | D | | P.dm | 216 | 10.79 | 1 | 20 | 4 | 560 | I | -24 | -25 | 0 | -22 | -13 | 17 | 0 | 2 | 1 | -1 | -5 | | | |
11/22/16 17:01 | 11/21/16 | FLML | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | I0 | DO | CEO | P.d | 21 | 10.64 | 1 | 2 | 1 | 193 | D | -24 | -22 | 5 | -28 | -17 | -2 | -2 | 2 | 1 | 3 | -2 | | | |
9/23/16 16:44 | 9/22/16 | FLML | Health | Drug | Pharmaceutical Preparations | Fildes Francis | I0 | D | | S.d | -202 | 13.45 | 2 | -15 | -50 | 15 | D | -7 | -33 | 28 | 37 | 6 | -1 | 1 | -1 | -3 | -12 | -11 | -25 | | |
9/7/16 18:58 | 9/2/16 | FLML | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | I0 | DO | CEO | P.d | 28 | 14.12 | 2 | 2 | 1 | 191 | D | 0 | -37 | 71 | 31 | 11 | 5 | 3 | 5 | -1 | -7 | -12 | -29 | | |
9/6/16 17:27 | 9/1/16 | FLML | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | I0 | D | | P.d | 135 | 13.52 | 2 | 10 | 2 | 540 | D | 0 | -37 | 63 | 33 | 12 | 7 | 2 | 2 | 4 | -4 | -8 | -22 | | |
8/29/16 16:11 | 8/26/16 | FLML | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | I0 | D | | P.d | 275 | 13.76 | 2 | 20 | 4 | 530 | I | -6 | -39 | 58 | 30 | 10 | 6 | 0 | -8 | 0 | 1 | -7 | -22 | | |
8/22/16 16:53 | 8/22/16 | FLML | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | I0 | DO | CEO | P.d | 71 | 14.30 | 2 | 5 | 3 | 189 | D | -1 | -31 | 50 | 47 | 24 | 14 | 13 | 8 | 3 | -5 | -4 | -26 | | |
5/16/16 16:40 | 5/13/16 | FLML | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | I0 | D | | P.dm | 251 | 9.21 | 3 | 27 | 6 | 510 | D | -15 | -43 | -38 | 3 | -16 | -23 | -22 | -1 | 6 | 6 | 5 | 42 | 18 | |
5/16/16 16:39 | 5/12/16 | FLML | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | I0 | DO | CEO | P.d | 44 | 8.84 | 3 | 5 | 4 | 134 | D | -15 | -43 | -38 | 3 | -16 | -23 | -22 | -1 | 6 | 6 | 5 | 42 | 18 | |
3/22/16 18:38 | 3/22/16 | FLML | Health | Drug | Pharmaceutical Preparations | Thompson Phillandas T. | I0 | O | See Rema | P.d | 111 | 11.10 | 4 | 10 | 100 | 20 | D | -24 | -37 | -52 | -16 | 22 | 43 | 29 | 8 | -2 | -4 | 4 | -15 | 23 | |
3/21/16 12:45 | 3/18/16 | FLML | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | I0 | DO | CEO | P.d | 55 | 11.04 | 3 | 5 | 4 | 129 | D | -19 | -37 | -55 | -22 | 16 | 24 | 34 | 6 | 4 | -2 | 6 | -13 | 25 | |
3/21/16 12:44 | 3/18/16 | FLML | Health | Drug | Pharmaceutical Preparations | Hatten Sandra L | I0 | O | SVP,Qual | P.d | 33 | 11.01 | 3 | 3 | New | 3 | D | -19 | -37 | -55 | -22 | 16 | 24 | 34 | 6 | 4 | -2 | 6 | -13 | 25 | |
3/16/16 16:48 | 3/14/16 | FLML | Health | Drug | Pharmaceutical Preparations | Stapleton Craig R | I0 | D | | P.d | 1,039 | 10.39 | 3 | 100 | 26 | 482 | D | -4 | -42 | -57 | -25 | 4 | 12 | 18 | 17 | 7 | 8 | 9 | -6 | 31 | |
3/16/16 16:46 | 3/14/16 | FLML | Health | Drug | Pharmaceutical Preparations | Anderson Michael S | I0 | DO | Chief Ex | P.d | 97 | 9.74 | 3 | 10 | 9 | 124 | D | -4 | -42 | -57 | -25 | 4 | 12 | 18 | 17 | 7 | 8 | 9 | -6 | 31 | |